More Effort is Needed to Inform Black Patients With Metastatic Breast Cancer to Increase Clinical Trial Participation

Written by on June 1, 2022

Black patients with metastatic breast cancer are less likely to trust and participate in clinical trials due to a lack of information and assurance of equal treatment, according to the results of a recent survey.

Among racial and ethnic groups in the United States, Black patients who have breast cancer have the highest death rate and shortest survival — however, they are the least likely to enroll in clinical trials. Specifically, 15% of patients with . . .



Current track

Title

Artist